Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer with a high mortality rate and characterized by ...
2d
Pharmaceutical Technology on MSNITM targets US approval for radiopharmaceutical after Phase III readoutITM Isotope Technologies Munich SE is gearing up to enter the US market with its radiopharmaceutical therapy, ITM-11 ...
The FDA is expected to decide on treatments for dry eye disease, neuroendocrine tumors, chronic spontaneous urticaria, Barth syndrome, and migraine.
ITM, a pioneer in radiopharmaceuticals, said it will submit its first drug for approval after reporting the therapy halted ...
But when it came to the secondary endpoint of interim overall survival (OS), the ITM-11 cohort reached 63.4 months while the ...
3d
MedPage Today on MSNAI and Mammography; Breast Cancer and Sexual Well-Being; Malaria Drug for Cancer?Breast cancer patients who underwent postmastectomy breast reconstruction had lower sexual well-being scores compared with ...
In this randomized controlled trial, cabozantinib significantly improved progression-free survival in patients with ...
In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumors (NETs), a rare but increasingly prevalent ...
A review in Brain Medicine unveils the potential of targeted alpha particle therapy (TAT) as an innovative and exciting ...
Huntsman Cancer Institute's Discovery Innovations showcase the latest advances in cancer treatment, research, and prevention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results